Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1837 of 6351
-
Implanted sensors could personalize PAH drug plans
Disease control OngoingThe goal of this clinical trial is to evaluate the capacity of implantable/remote technology for early evaluation of drug therapies in patients with pulmonary arterial hypertension (PAH). The main question it aims to answer is whether structured changes in clinical therapy will b…
Phase 4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can less be more? new study tests a gentler dosing schedule for advanced bladder cancer drug
Disease control OngoingThis is a non-randomized two arm open-label phase 2 pilot study in adult subjects with locally advanced or metastatic urothelial cancer. The study will investigate an alternative administration schedule of EV given as monotherapy and in combination with pembrolizumab.
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Office-Based clot buster: new device aims to clear leg veins fast
Disease control OngoingA post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
Sponsor: Paul J. Gagne • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Lung cancer drug matching: lab test could personalize treatment
Knowledge-focused Recruiting nowThis observational study evaluates if ex-vivo lung cancer drug sensitivity testing results correlate with the driver mutations found by genetic sequencing and if it can predict treatment response.
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Simple glove trick may shield breast cancer patients from chemo nerve pain
Prevention OngoingThis study aims to demonstrate the preventive effect of compression therapy using surgical gloves in chemotherapy-induced peripheral neuropathy. Patient-reported outcome measures (PROMs) are utilized for comparing the change in neuropathic pain between intervention and control gr…
Sponsor: Young-Joon Kang • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control Stopped earlyStudy CP-MGC018-03 is an open-label, two-part, Phase 2 study. Part 1 of the study will enroll participants with metastatic castration-resistant prostate cancer (mCRPC) previously treated with one prior androgen receptor axis-targeted therapy (ARAT). ARAT includes abiraterone, enz…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Hip implant tracked for a decade: will it last?
Disease control CompletedThis clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in rel…
Sponsor: Societe dEtude, de Recherche et de Fabrication • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Heart drug showdown: which statin spares your blood sugar?
Disease control Recruiting nowThe purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New study checks if filgotinib keeps ulcerative colitis in check Long-Term
Disease control OngoingTo describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world setting.
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control PausedThis phase I trial tests the safety, side effects, and best dose of emavusertib (CA-4948) in combination with gemcitabine and nab-paclitaxel in treating patients with pancreatic ductal adenocarcinoma that has spread from where it first started (primary site) to other places in th…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 05:00 UTC
-
New hope for hard-to-treat cancers: experimental combo targets STK11 mutation
Disease control OngoingThe goal of this interventional clinical trial is to learn about TNG260, a CoREST inhibitor, in combination with pembrolizumab in patients with advanced solid tumors with a known STK11 mutation. The main question\[s\] it aims to answer are: * the recommended dose for Phase 2 * …
Phase 1/2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to supercharge immune system against prostate cancer
Disease control Recruiting nowBackground: Prostate cancer is often treated with radiation and ADT (ADT is androgen deprivation therapy). Up to 30% of these cancers recur within 5 years of treatment. Researchers want to see if a new drug (PDS01ADC) can help the immune system to fight prostate cancer. Objecti…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a new PET scan pinpoint the cause of Cushing's syndrome?
Diagnosis Recruiting nowIn previous clinical practice, 68Ga-Pentixafor PET/CT has demonstrated promising diagnostic utility in various neuroendocrine tumors by targeting CXCR4, a chemokine receptor overexpressed in several ACTH-secreting neoplasms. Building on this, and leveraging the Nuclear Medicine e…
Phase 1/2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Zinc gel may outsmart recurring yeast infections
Disease control CompletedVaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than 85% of vaginal fungal infections and reinfection after standard treatment is quite common. The aim of this study is to compare the effects of a zinc-containing vagin…
Sponsor: FEMPHARMA Kft. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can cleaning up blocks and offering financial help boost Kids' health?
Knowledge-focused CompletedBlack children and adults in the United States fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities result in a stark longevity gap, with average life expectancies in poor, predominant…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Which ablation method best prevents stroke in atrial fibrillation?
Disease control Recruiting nowAtrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke in patients with AF is often fatal and, compared with stroke of other etiology, leads to the most pronounced disability…
Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a structured nursing program boost quality of life in advanced lung cancer?
Symptom relief CompletedSymptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.
Sponsor: Jie Zeng • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New study aims to unlock why Anti-TNF drugs heal some Kids' Crohn's but not others
Disease control Recruiting nowCrohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. Whi…
Phase 4 • Sponsor: Connecticut Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a model predict the right dose of rifampicin for bone infections?
Knowledge-focused Recruiting nowStaphylococcal osteoarticular infections (OAIs), including prosthetic joint infections and chronic osteomyelitis, represent a major cause of morbidity. Rifampicin is a key bactericidal antibiotic effective against staphylococcal biofilm. However, its pharmacokinetics exhibit subs…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New hybrid Closed-Loop pump could ease diabetes management
Disease control CompletedTreatment of Type 1 diabetes requires daily insulin therapy given by either multiple daily injections or by continuous infusion via a pump. The insulin dose is calculated taking into consideration blood glucose levels, food intake and activity levels, aiming to avoid high and low…
Sponsor: NHS Lothian • Aim: Disease control
Last updated Jun 26, 2026 17:33 UTC